The persistence of normal thymidine nucleotidase (ThyNase) activity in subjects with pyrimidine nucleotidase (PyrNase) Recognition of the existence of pyrimidine-specific nucleotidase (PyrNase) evolved from studies of patients who shared an unusual hemolytic syndrome in which affected erythrocytes (i) retained 10% or less of normal PyrNase activity, (ii) accumulated enormous quantities of cytidine and uridine nucleotides, and (iii) exhibited prominent basophilic stippling with Wright's stain (1). None of these alterations occurs in heterozygous relatives, who have 40-60% of con-
Nucleotidases (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) constitute a large class of heterogeneous isozymes widely distributed among animals, plants, and microorganisms. They mediate hydrolysis of monophosphate ester linkages with the fifth carbon of ribose or deoxyribose in various 5'-nucleotides, producing inorganic phosphate (Pi) and the corresponding nucleoside. Nucleotidase isozymes from different sources vary in substrate preferences, kinetics, cation requirements, pH optima, and other characteristics, but virtually all are active with 5'-nucleotides of both purine and pyrimidine bases.
A decade ago, we observed that lysates of normal human erythrocytes contained nucleotidase activity that was apparently limited to pyrimidine substrates (uridine, cytidine-, and thymidine 5'-monophosphates; UMP, CMP, dTMP) (1, 2). Unlike nucleotidases from other sources, the human erythrocyte isozyme was inactive with purine analogues when assayed in the region of pH 7.5 . This unique substrate restriction seemed a logical evolutionary development in anucleate red cells, whose viability critically depends upon a limited reservoir of high-energy ATP, the purine base of which cannot be synthesized de novo. An erythrocyte nucleotidase that was also capable of dephosphorylating AMP to diffusible adenosine theoretically should impose an inexorable drain on the adenine nucleotide pool, the components of which are in rapid equilibrium through the mediation of adenylate kinase.
Recognition of the existence of pyrimidine-specific nucleotidase (PyrNase) evolved from studies of patients who shared an unusual hemolytic syndrome in which affected erythrocytes (i) retained 10% or less of normal PyrNase activity, (ii) accumulated enormous quantities of cytidine and uridine nucleotides, and (iii) exhibited prominent basophilic stippling with Wright's stain (1) . None of these alterations occurs in heterozygous relatives, who have 40-60% of control PyrNase activity and are clinically and hematologically normal.
Marked hereditary deficiency of PyrNase is now recognized as one of the most common erythrocyte enzyme defects associated with chronic hemolytic anemia (3, 4) . The hematologic alterations of the syndrome may be precisely duplicated by severe lead intoxication (5, 6) , since PyrNase is exquisitely sensitive to inactivation by lead (2, 7) .
In recent attempts to detect molecular heterogeneity among PyrNase deficiencies, we added dTMP to other substrates (UMP, CMP, AMP) used in our standard PyrNase assay. We had previously found dTMP to be an effective substrate for PyrNase activity in normal hemolysates (2) , but it has not been used routinely in studies of patients with PyrNase deficiency. In the first case so studied, we found that dTMP was actively dephosphorylated by hemolysates that had less than 10% of normal mean PyrNase activity with UMP or CMP (8) . Similar results were observed independently by Swallow et al. (9) Effects of lead on PyrNase activity were studied by using hemolysates dialyzed overnight against 1.0 M acetate buffer, pH 8.0 (in place of Tris HCl), containing 10 mM MgCl2 or Mg(C2H302)2 but devoid of EDTA. The overnight dialysis was performed in the presence of 1 mM mercaptoethanol, but that compound was deleted from a second 2-hr dialysis prior to lead exposure and assay. Pb(C2H302)2-3H2O was added directly to aliquots of hemolysate to achieve final concentrations of Pb2+ between 10-1 and 10-7 M. After 20 min at 37°C, each was assayed in 0.3 M acetate buffer with 8.5 mM MgCl2 or Mg(C2H302)2, but devoid of dithiothreitol, using pH 6.0 or 7.0 buffers with dTMP or UMP, respectively, as substrates.
RESULTS
Substrate Specificity. Data presented in Table 1 demonstrate distinct and consistent segregation of nucleotidase activities dependent upon substrate. Hemolysates from subjects with marked PyrNase deficiency (homozygous or compound heterozygous) exhibited minimal activity with UMP, CMP, or dCMP but were briskly active with both dTMP and dUMP. All heterozygous relatives studied had intermediate activities with UMP, CMP, and dCMP and entirely normal activities with dTMP and dUMP.
Individual values shown in Table 1 are means of two to four separate determinations utilizing the standard pH 7.4 assay system with substrates at 2.3 mM final concentration. Neither pH nor substrate concentration was necessarily optimal for deoxyribonucleotides, but conditions were adequate for comparative purposes. Young cells and reticulocytes have significantly increased PyrNase activities with UMP and CMP (2) but not with dTMP under these suboptimal conditions.
The observation of normal nucleotidase activity for dTMP and dUMP confirms similar findings in single cases of PyrNase deficiency reported by Swallow et al. (9) and ourselves (8) .
pH Optima. Similar segregation of activities occurred when PyrNase was measured as a function of pH. As shown in Fig. 1 , dephosphorylation of dTMP and dUMP in normal control hemolysates was optimal around pH 6.2, whereas UMP and CMP produced broadly plateaued curves with maxima in the region of pH 7.2. The activity curve with dCMP was identical to that of UMP in the lower pH range, but peaked at pH 6.8 and decayed more rapidly under alkaline conditions. Activities with UMP, dUMP, dCMP, and dTMP were quantitatively comparable at pH 7.2-7.4 used in the standard assay system. In sharp contrast to previous studies with PyrNase, the purine substrates, AMP and dAMP, were both effectively dephosphorylated by normal control hemolysates if assayed in the region of pH 5.5-6.7. The contour of the dAMP curve in Fig. 1 those obtained with dAMP and were identical in pH dependence.
As shown in Fig. 2 , heterozygous relatives with partial PyrNase deficiency had entirely normal ThyNase activity. Their PyrNase activity curves with UMP were normal in configuration but reduced in magnitude.
In subjects with severe PyrNase deficiency, however, there was a distinct shift in optimal pH for UMP dephosphorylation. As shown in Fig. 3 , optimal pH was approximately 6.2 for both dTMP and UMP, and activity with the latter substrate was markedly reduced. One deficient subject (M.R.) tested additionally with dUMP, dCMP, and CMP had a similar acidic pH optimum for all five substrates (Fig. 4) . In this case, CMP was poorly but progressively dephosphorylated as pH was decreased, possibly as a result of acid phosphatase activity.
It is clear from these curves that ThyNase activity measured in the standard system at pH 7.4 may be only half that obtainable at its more optimal acidic pH. The data in Table 1 for clearance of pyrimidine degradation products of RNA during normal reticulocyte maturation (1) , and it is the one that is defective in cases of hereditary or Pb2'-induced PyrNase deficiency (5-7). Another isozyme (or isozymes), which we had tentatively designated ThyNase (8) , operates optimally at acidic pH and is apparently active not only with dTMP but also with dUMP, dAMP, and dCMP. The relative resistance to in vitro inactivation by Pb 2+ suggests that this isozyme will likely retain significant activity in patients with sufficient lead intoxication to induce deficiency of PyrNase.
The distinction between these isozymes was confirmed by studies of heterozygous and compound heterozygous or homozygous subjects with PyrNase deficiency. Diminished activity of the PyrNase isozyme unmasked the existence of the second isozyme and permitted partial characterization on the basis of substrate specificity and kinetics, pH optima, and heavy-metal inhibition.
The persistence of ThyNase activity that we observed previously in a single case of hereditary PyrNase deficiency (8) , and which was observed independently by Swallow et al. (9) in another case, remained consistent in seven additional subjects with severe or intermediate deficiencies of PyrNase. Such findings in isolated instances conceivably could result from genetically induced alterations in molecular structure that affected substrate specificity or avidity, but the persistent presence of highly active ThyNase in all of these unrelated PyrNase-deficient subjects effectively eliminates any reservations about the existence of separate isozymes. This conclusion was additionally supported by the distinct difference between PyrNase and ThyNase in their sensitivities to Pb2+ inactivation (Fig. 6) and by the loss of normal distinctions between Km(UMP) and Km(dTMP) in PyrNase-deficient hemolysates (Fig. 5) .
When other nucleoside monophosphates were tested as potential substrates, it became clear that residual nucleotidase activity in PyrNase-deficient hemolysates was not limited to dTMP alone. In our standard assay system at a final pH of 7.4, dUMP was also actively dephosphorylated, but dCMP was not (Table 1) . Assays at lower pH, however, showed dCMP to be moderately effective as substrate (Fig.  4) .
The marked difference between dCMP curves in Figs. 1 and 4 indicates that dCMP can serve as substrate for both Pyr- Nase and the residual isozyme in PyrNase-deficient cells. Data in Fig. 3 additionally suggested that the PyrNase isozyme had some degree of crossreactivity for dTMP, since most of the deficient subjects exhibited slightly more rapid decrescence of ThyNase activity at alkaline pH than did normal controls.
An unexpected, but highly significant, finding was the effectiveness with which normal control hemolysates dephosphorylated dAMP (and, to a lesser extent, AMP) in the region of pH 6 (Fig. 1) . To our knowledge, such vigorous activity with a purine substrate has not been demonstrated previously in normal erythrocytes, and it clearly removes the responsible isozyme from the class of pyrimidine-specific nucleotidases.
All of these data are consistent with the hypothesis that normal human erythrocytes contain two distinct 5'-nucleotidases, PyrNase and a second isozyme with the following characteristics: (i) variably active with both purine and pyrimidine substrates (dUMP > dTMP > dAMP > dCMP > AMP > UMP); (ii) principally dependent upon (but not restricted to) the 2'-deoxyribose moiety for substrate recognition; (iii) optimally active in the region of pH 6.2; and (iv), relative to PyrNase, significantly (10-100 times) more resistant to sulfhydryl inhibition by Pb2+. Such an isozyme might best be classified as a deoxyribonucleotidase (2'-deoxy-5'-ribonucleotide phosphohydrolase, dNase). Compared to PyrNase, dNase is less limited in substrate specificity and so more closely resembles the 5'-nucleotidases found ubiquitously throughout nature in terms of being variably active with a variety of both purine and pyrimidine substrates. Although it was catalytically more effective with deoxyribonucleotide substrates, dNase appeared to crossreact significantly with each corresponding ribonucleotide, possibly excepting CMP. The present data do not exclude the possibility that multiple isozymes exist that are more or less specific for each substrate or class of substrates-e.g., ThyNase, deoxypyrimidine nucleotidase, etc.
Our findings further suggest that the slight residual activities observed in cases of severe hereditary deficiency of PyrNase are most likely due to dNase acting on UMP or CMP, with little or no contribution by the defective PyrNase isozyme. The variations in pH optima, kinetic constants, thermostability, and electrophoretic migration reported by Rosa et al. (12) , Fujii et al. (13) , Shinohara and Tanaka (14) , and Ishida et al. (15, 16) in other deficient cases may not be due to molecular alteration of residual PyrNase as presumed, or to a minor PyrNase isozyme as postulated by Rosa et al. (12) , but more likely represent characteristics of the normal dNase isozyme no longer obscured by significant PyrNase activity. Their studies employed partially purified enzyme preparations and UMP or CMP as substrate, and they found pH optima variously shifted from the 7.0-8.0 region to approximately pH 5.7-6.1 and Km(UMP) or Km(CMP) increased severalfold, consistent with our findings for the dNase isozyme.
Similarly, the biphasic pH optima noted by Torrance and Whittaker (17) with PyrNase purified from normal erythrocytes may also have been due to the dNase isozyme. They found UMP and CMP to be optimally dephosphorylated at pH 7.2 with a minor peak at pH 6.3. They also detected slight activity with purine substrates (AMP and GMP) that was optimal at pH 6.1 with a minor peak at pH 7.2. Shinohara and Tanaka (14) additionally found purified preparations from PyrNase-deficient erythrocytes to have comparable activities with UMP and AMP at pH 8.0.
The extreme susceptibility of erythrocyte PyrNase to inactivation by Pb2+ is well documented (4) and is presumed to be due to its dependence on sensitive sulfhydryl groups for proper molecular conformation. PyrNase is inactivated in vitro and in vivo by Pb2+ concentrations too low to have significant effects on other erythrocyte enzymes of glycolysis, glutathione, and nucleotide metabolism (7). It therefore seems possible that PyrNase might not tolerate many genetically induced alterations in primary structure without virtually complete loss of catalytic effectiveness. If this were the case, it would leave only the dNase isozyme, which inefficiently hydrolyzes UMP or CMP at alkaline pH, the conditions traditionally used for quantitative assays of PyrNase. This might account for the apparent absence of disparate mutant PyrNase isozymes that reflect the phenotypic heterogeneity so characteristic of other erythroenzymopathies, such as those of pyruvate kinase and glucosephosphate isomerase.
The evolution of an enzyme system as specific as erythrocyte dNase suggests specific physiologic functions. Since dNase is active principally with deoxyribonucleotides, including dAMP, it might logically be expected to dephosphorylate degradation products of DNA in a manner analogous to that presumed for PyrNase in RNA degradation. This would imply that nuclear pyknosis and pitting, phenomena that are well documented morphologically in maturing erythroblasts (18) (19) (20) , might be accompanied by sufficient karyolytic degradation of DNA to require a mechanism for dephosphorylation of resultant deoxyribonucleotides to diffusible nucleosides. Awai et al. (21) cited the absence of detectable [3H]thymidine label in reticulocytes as evidence against even partial karyolysis, but dNase activity might account for their observations and negate their conclusion.
A deficiency state for dNase remains undetected. Should one be identified, the study of its effects should provide valuable insights into the physiologic function of this unique enzyme system.
